Inactive Instrument

The Flowr Corporation

FLWR.H

CA34354X1087

The Flowr Corporation Announces Resignation of Stephen Arbib as Director

October 17, 2022 at 05:30 pm EDT

The Flowr Corporation announced that Stephen Arbib has resigned from the board of directors of the Company effective immediately.

Latest news about The Flowr Corporation

Avant Brands K1 Inc. (formerly 1000343100 Ontario Inc.) completed the acquisition of The Flowr Group Inc. from The Flowr Corporation (TSXV:FLWR.H) for CAD 5.12 million.	23-02-01	CI
The Flowr Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-27	CI
1000343100 Ontario Inc. entered into a Stalking Horse Purchase Agreement to acquire The Flowr Group Inc from The Flowr Corporation (TSXV:FLWR.H) for CAD 0.89 million.	22-10-31	CI
The Flowr Corp Files for Court Protection From Creditors	22-10-20	MT
The Flowr Corp. Brief: Says To File for CCAA Protection	22-10-20	MT
The Flowr Corporation Announces Resignation of Stephen Arbib as Director	22-10-17	CI
The Flowr Corporation Announces the Resignation of Joanne Lee from the Board of Directors	22-09-30	CI
Transcript : The Flowr Corporation - Shareholder/Analyst Call	22-09-28
The Flowr Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-29	CI
The Flowr Corp. Brief: Announcing Close of Sale of Flowr Forest for $3.4 Million Completing Phase One of the Transformation Plan	22-08-15	MT
The Flowr Corp. Details Leadership Transition and Changes to Board of Directors	22-08-10	MT
The Flowr Corp. Brief: Includes Appointment of Darren Karasiuk to the Role of Chief Executive Officer	22-08-10	MT
The Flowr Corp. Brief: Details Leadership Transition and Changes to Board of Directors	22-08-10	MT
The Flowr Corporation Announces Management Changes	22-08-10	CI
The Flowr Corporation Appoints Darren Karasiuk as Chief Executive Officer	22-08-10	CI
Hawthorne Canada Limited completed the acquisition of KRS Facility in Kelowna from The Flowr Corporation.	22-07-26	CI
The Flowr Corporation Announces Resignation of Noel Biderman as Director	22-07-12	CI
The Flowr Reports Resignation of Directors	22-07-04	MT
The Flowr Corporation Announces Resignation of Directors	22-07-04	CI
The Flowr Corp Up 25% as Slashes Headcount by 40%, Agrees to Sell Non-Core Asset for $3.4 Million	22-06-24	MT
The Flowr Corp Slashes Headcount by 40%, Agrees to Sell Non-Core Asset for $3.4 Million	22-06-24	MT
The Flowr Corporation Announces Headcount Reduction	22-06-23	CI
The Flowr Corp Falls 20% as Trading Reinstated; Q1 Net Loss $6.1 Million Vs $8.3 Million Year Ago	22-05-31	MT
The Flowr Corporation Q1 Net Loss $6.1 Million Vs $8.3 Million Year Ago; Says Trading in Shares Reinstated	22-05-31	MT
The Flowr Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-29	CI

The Flowr Corporation is a Canada-based cannabis company. The principal activity of the Company is the production and sale of premium cannabis in Canada, and medical cannabis products in other legal global markets, primarily Portugal and the European Union. It is focused on producing, marketing, and distributing dried cannabis flower products, such as packaged dried cannabis flower and pre-rolls, and intends to offer product formats such as cannabis oils, vape technology, edibles, beverages and topical products. The Company primarily operates through two segments: Flowr Canada, which is a licensed producer operating in Canada, and Holigen, which is a licensed producer with operations primarily in Portugal. Its brands include Flowr and FlowrRX. Its subsidiaries include The Flowr Canada Holdings ULC, Holigen Holdings Limited, Holigen Limited, The Flowr Group (Okanagan) Inc., RPK Biopharma Unipessoal Lda, TCann Pty Ltd and GreyCan Pty Ltd.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+35.04%	5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B

Alternative Medicine